Company intelligence / Profile preview

o2h human health EIS Fund

Cambridge, Cambridgeshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

The o2h human health EIS Fund is a specialized investment vehicle managed by o2h Ventures, focusing on early-stage biotech and health-tech opportunities in the UK. It is the first S/EIS fund in the UK solely dedicated to investing in drug discovery and therapeutic assets. The fund leverages the deep domain expertise of the o2h Group to identify and support high-potential startups through seed and Series A rounds. Its portfolio includes a diverse range of companies working on innovative treatments, diagnostics, and digital health solutions. By providing both capital and strategic mentorship, the fund aims to accelerate the development of next-generation human health technologies.

Industry: Investors

Beyond the preview

Go deeper on o2h human health EIS Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on o2h human health EIS Fund.

Explore the full profile